Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| NUS | NU SKIN ENTERPRISES, INC. | 2026-02-18 00:02:12 | 8.62 | 0.01 | 0.12 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NUS | 0001021561 | NU SKIN ENTERPRISES, INC. | US67018T1051 | 54930050DETB6CP71D38 | 870565309 | NYSE | 5122 | Wholesale-Drugs, Proprietaries & Druggists' Sundries | 1231 | DE | 75 WEST CENTER ST | PROVO | UT | 84601 | UNITED STATES | US | 801-345-1000 | 75 WEST CENTER ST, PROVO, UT, 84601 | 75 WEST CENTER ST, PROVO, UT, 84601 | NU SKIN ENTERPRISES INC | Multilevel marketing | 1984 | Ryan Napierski | 3,100 | http://nuskin.com | 518,000,000 | 90,600,000 | 48,750,076 | Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors. | 2026-02-12 18:36:44 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 390,000,000 | -128,000,000 | -24.7104 | 48,126,825 | -1,595,954 | -3.2097 |
| 2024 | 518,000,000 | -1,122,000,000 | -68.4146 | 49,722,779 | 301,897 | 0.6109 |
| 2023 | 1,640,000,000 | -530,000,000 | -24.424 | 49,420,882 | -39,239 | -0.0793 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Chayce D. Clark | EVP, General Counsel | 2024 | 595,984 | 1,000,000 | 1,647,035 | 113,438 | 106,933 | 3,463,389 |
| Steven K. Hatchett | EVP, Chief Product Officer | 2024 | 436,066 | 100,000 | 941,166 | 82,500 | 39,657 | 1,599,389 |
| Ryan S. Napierski | Chief Executive Officer, President | 2024 | 1,041,803 | 0 | 4,517,549 | 288,750 | 144,987 | 5,993,088 |
| James D. Thomas | Chief Financial Officer, EVP | 2024 | 491,803 | 800,000 | 1,035,271 | 93,750 | 92,032 | 2,512,856 |
| Justin S. Keisel | EVP, President | 2024 | 366,257 | 160,678 | 382,000 | 11,854 | 52,829 | 973,617 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 1,485,159,000 | 1,732,084,000 | 1,969,131,000 |
| Cost Of Revenue | 453,761,000 | 550,233,000 | 611,850,000 |
| Gross Profit | 1,031,398,000 | 1,181,851,000 | 1,357,281,000 |
| Research And Development Expenses | 10,800,000 | 13,000,000 | 22,600,000 |
| General And Administrative Expenses | 432,141,000 | 479,037,000 | 546,858,000 |
| Operating Expenses | 965,635,000 | 1,333,436,000 | 1,309,013,000 |
| Operating Income | 65,763,000 | -151,585,000 | 48,268,000 |
| Net Income | 160,204,000 | -146,594,000 | 8,595,000 |
| Earnings Per Share Basic | 3.25 | -2.95 | 0.17 |
| Earnings Per Share Diluted | 3.18 | -2.95 | 0.17 |
| Weighted Average Shares Outstanding Basic | 49,293,000 | 49,662,000 | 49,711,000 |
| Weighted Average Shares Outstanding Diluted | 50,301,000 | 49,662,000 | 49,860,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 238,630,000 | 186,883,000 | 256,057,000 |
| Marketable Securities Current | 1,211,000 | 11,111,000 | 11,759,000 |
| Accounts Receivable | 39,544,000 | 50,784,000 | 72,879,000 |
| Inventories | 178,643,000 | 190,242,000 | 279,978,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 13,114,000 | 13,719,000 | 17,918,000 |
| Total Assets Current | 547,698,000 | 538,599,000 | 701,871,000 |
| Marketable Securities Non Current | 4,434,000 | 39,590,000 | 36,374,000 |
| Property Plant And Equipment | 377,168,000 | 379,595,000 | 432,965,000 |
| Other Assets Non Current | 280,187,000 | 298,008,000 | 245,443,000 |
| Total Assets Non Current | 458,875,000 | 461,741,000 | 534,242,000 |
| Total Assets | 1,405,313,000 | 1,468,914,000 | 1,806,463,000 |
| Accounts Payable | 26,183,000 | 34,880,000 | 43,505,000 |
| Deferred Revenue | 12,737,000 | 15,688,000 | 20,388,000 |
| Short Term Debt | 20,000,000 | 30,000,000 | 25,000,000 |
| Other Liabilities Current | 217,551,000 | 217,808,000 | 260,366,000 |
| Total Liabilities Current | 263,734,000 | 296,607,000 | 328,871,000 |
| Long Term Debt | 204,187,000 | 363,613,000 | 478,040,000 |
| Other Liabilities Non Current | 74,512,000 | 97,475,000 | 106,641,000 |
| Total Liabilities Non Current | 336,339,000 | 520,852,000 | 655,624,000 |
| Total Liabilities | 600,073,000 | 817,459,000 | 984,495,000 |
| Common Stock | 91,000 | 91,000 | 91,000 |
| Retained Earnings | 1,860,319,000 | 1,711,949,000 | 1,870,470,000 |
| Accumulated Other Comprehensive Income | -116,105,000 | -124,758,000 | -100,006,000 |
| Total Shareholders Equity | 805,240,000 | 651,455,000 | 821,968,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 52,261,000 | 69,810,000 | 70,923,000 |
| Share Based Compensation Expense | 24,105,000 | 14,823,000 | 15,646,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | -10,055,000 | 7,763,000 | 22,679,000 |
| Change In Inventories | -11,887,000 | -30,318,000 | 13,222,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | 8,577,000 | 1,054,000 | -45,000 |
| Change In Accounts Payable | -9,112,000 | -7,294,000 | -10,083,000 |
| Change In Other Liabilities | 858,000 | -15,539,000 | -4,402,000 |
| Cash From Operating Activities | 80,286,000 | 111,742,000 | 118,639,000 |
| Purchases Of Marketable Securities | 0 | 14,757,000 | 16,883,000 |
| Sales Of Marketable Securities | 10,214,000 | 18,378,000 | 18,147,000 |
| Acquisition Of Property Plant And Equipment | 34,277,000 | 41,583,000 | 58,490,000 |
| Acquisition Of Business | 0 | 0 | 77,275,000 |
| Other Investing Activities | -1,000,000 | — | — |
| Cash From Investing Activities | 170,662,000 | -37,962,000 | -134,501,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 11,834,000 | 11,927,000 | 77,622,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 20,040,000 | 0 | 13,011,000 |
| Issuance Of Long Term Debt | 55,000,000 | 15,000,000 | 110,000,000 |
| Repayment Of Long Term Debt | 225,000,000 | 125,000,000 | 10,000,000 |
| Other Financing Activities | 3,620,000 | — | — |
| Cash From Financing Activities | -202,404,000 | -133,176,000 | 10,730,000 |
| Change In Cash | 51,747,000 | -69,174,000 | -8,668,000 |
| Cash At End Of Period | 238,630,000 | 186,883,000 | 256,057,000 |
| Income Taxes Paid | 40,817,000 | 30,400,000 | 32,400,000 |
| Interest Paid | 16,700,000 | 35,300,000 | 33,300,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 3.25 | -2.95 | 0.17 |
| Price To Earnings Ratio | 2.96 | -2.3356 | 114.2353 |
| Earnings Growth Rate | -210.1695 | -1,835.2941 | -91.9048 |
| Price Earnings To Growth Ratio | -0.0141 | 0.0013 | -1.243 |
| Book Value Per Share | 16.3358 | 13.1178 | 16.5349 |
| Price To Book Ratio | 0.5889 | 0.5252 | 1.1745 |
| Ebitda | 267,230,000 | -19,975,000 | 137,518,000 |
| Enterprise Value | 459,755,660 | 548,901,180 | 1,212,370,620 |
| Dividend Yield | 0.025 | 0.0349 | 0.0804 |
| Dividend Payout Ratio | 0.0739 | -0.0814 | 9.0311 |
| Debt To Equity Ratio | 0.2784 | 0.6042 | 0.612 |
| Capital Expenditures | 49,834,000 | 16,440,000 | 59,082,000 |
| Free Cash Flow | 30,452,000 | 95,302,000 | 59,557,000 |
| Return On Equity | 0.199 | -0.225 | 0.0105 |
| One Year Beta | 1.0231 | 0.5412 | 0.9655 |
| Three Year Beta | 0.8932 | 0.858 | 0.9204 |
| Five Year Beta | 0.9023 | 0.7682 | 0.802 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| NAPIERSKI RYAN S | Director, President and CEO | 2026-02-10 | 42,970 | A | 686,403 |
| NAPIERSKI RYAN S | Director, President and CEO | 2026-02-10 | 206,988 | A | 893,391 |
| Thomas James D | Chief Financial Officer | 2026-02-10 | 9,847 | A | 145,287 |
| Thomas James D | Chief Financial Officer | 2026-02-10 | 47,436 | A | 192,723 |
| Clark Chayce David | EVP and General Counsel | 2026-02-10 | 15,667 | A | 239,758 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| EP Wealth Advisors, LLC | 2025-12-31 | 691,978 | 71,931 | 9.62 |
| LAZARD ASSET MANAGEMENT LLC | 2025-12-31 | 1,691,513 | 175,833 | 9.62 |
| AQR CAPITAL MANAGEMENT LLC | 2025-12-31 | 7,687,534 | 799,120 | 9.62 |
| Brevan Howard Capital Management LP | 2025-12-31 | 187,879 | 19,530 | 9.62 |
| CITADEL ADVISORS LLC | 2025-12-31 | 177,970 | 18,500 | 9.62 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| GMO TRUST | 2025-11-30 | Class VI | GCAVX | 6,813 | 67,380.57 | 0.1687 |
| ETF Series Solutions | 2025-11-30 | Acquirers Small and Micro Deep Value ETF | DEEP | 21,306 | 210,716.34 | 0.845 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 2025-11-30 | SIIT Extended Market Index Fund - Class A | SMXAX | 8,205 | 81,147.45 | 0.0067 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 2025-11-30 | SIIT Multi-Asset Real Return Fund - Class A | SEIAX | 1,445 | 14,291.05 | 0.0018 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 2025-11-30 | Invesco Russell 2000(R) Dynamic Multifactor ETF | OMFS | 13,270 | 131,240.3 | 0.0509 |